Innovative Curing and Tire Building Forum – Marc Flederus presents

Get ready for The 2nd Annual Innovative Curing and Tire Building Forum – December 13-14, 2018 in Berlin, Germany.

Marc Flederus
VP of Ferm RFID
a Division of FineLine Technologies

Get ready for The 2nd Annual Innovative Curing and Tire Building Forum – December 13-14, 2018 in Berlin, Germany. Industry leaders  will discuss the latest innovations and developments of the two most challenging processes of tire curing and tire building, as these account for the largest percentage of energy consumption within tire production plants.

The forum displays and examines the best insights from the latest research from around the globe. The Innovative Curing and Tire Building Forum brings together industry leaders to present on and discuss the latest innovations and developments in curing and tire building.

Join Marc Flederus, VP of Ferm RFID, a Division of FineLine Technologies as he discusses how RFID tagging solutions can enhance functionality, efficiency and environmental ambitions for the worldwide tire industry.

Learn more about this conference.

Share

MORE NEWS

FineLine Technologies Acquires Digi-Trax, Marking FineLine’s Expansion in the Healthcare Industry

FineLine Technologies announces its acquisition of Digi-Trax Corp., a leading provider of healthcare labeling and identification solutions that support safety, traceability and compliance in the blood and cell-therapy supply network. Digi-Trax will operate as FineLine’s new Healthcare Division.

FineLine Executes Rapid Fulfillment of 30 Million Cover-Up Labels to Nearly 4,000 Stores for Major U.S. Retailer in Just Four Days 

FineLine Technologies successfully delivered 30 million cover-up labels to nearly 4,000 stores for a major U.S. retailer in only four days.

FineLine Showcases RFID, Barcode, and Traceability Innovations at GS1 Connect 2025

FineLine showcases RFID and 2D barcode solutions at GS1 Connect 2025, supporting traceability, compliance, and efficiency across global retail, food, and pharma supply chains.
Search